For this aim, both ALDH+ and ALDH- SKBR-3 breast and HCT-116 colon cancer subpopulations were treated with the IC50 and twice the IC50 of Bozepinib values for 24 hours. The gene discussed is LDHA; the disease is malignant colon neoplasm.